Infrastructure and Informatics: The Modern Backbone of Discovery

Session Topics:

Robust infrastructure is not a luxury reserved for well-resourced enterprises. It's a strategic enabler for any organization serious about drug discovery. For smaller organizations, the challenge lies in achieving the same standards of data integrity, scalability and connectivity with fewer resources. This session will examine how research organizations — from large pharmaceutical companies to lean biotechs — build and sustain the informatics and IT infrastructure that powers scientific discovery.

Additional Topics:

• Informatics architecture for small molecule and biologics programs
• Inventory management, ordering systems, and instrument interfaces
• Database design for scalability and interoperability
• IT when you don't have IT internally—small biotech, not just large pharma

Session Chair:

James Craven
Chief Commercial Officer (Simplicis)

Speakers:

Anita Vrcic, MS
Senior Team Lead - Compound Management (Broad Institute of MIT and Harvard)

Presenting:
Broadening Horizons: From Legacy Solutions to Enterprise Platform in Sample Management

Caitlin O'Brien
Compound Manager (Flare Therapeutics)